Charles River Laboratories (CRL)
Current ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 1,403,070 | 1,608,660 | 1,439,030 | 1,274,100 | 1,201,130 |
Total current liabilities | US$ in thousands | 994,101 | 1,055,080 | 1,091,580 | 1,033,180 | 839,751 |
Current ratio | 1.41 | 1.52 | 1.32 | 1.23 | 1.43 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,403,070K ÷ $994,101K
= 1.41
The current ratio of Charles River Laboratories has shown some fluctuation over the past five years based on the provided data. As of December 31, 2020, the current ratio stood at 1.43, indicating the company had $1.43 in current assets for every $1 in current liabilities.
However, by December 31, 2021, the current ratio had decreased to 1.23, suggesting a slight weakening of the company's ability to cover its short-term obligations with its current assets. This trend continued in the following year, with the current ratio improving to 1.32 by December 31, 2022.
As of December 31, 2023, the current ratio strengthened further to 1.52, indicating a healthier liquidity position for Charles River Laboratories. Nonetheless, by December 31, 2024, the current ratio had dropped slightly to 1.41, although it still remained above 1, signifying the company's ability to meet its short-term obligations.
Overall, while the current ratio has displayed some variability, it generally suggests that Charles River Laboratories has maintained a reasonable level of liquidity and ability to cover its short-term liabilities over the five-year period.
Peer comparison
Dec 31, 2024